pocketful logo light
pocketful logo light
Thyrocare Technologies Ltd logo

Thyrocare Technologies Ltd

NSE: THYROCARE BSE: 539871

₹579

(2.10%)

Sun, 09 Aug 2026, 05:25 pm

mtf coin illustrationMTF 5x

Thyrocare Technologies Share Price Live Chart

1 Day

(2.10%)

No Result Found

Summary

  • Market Cap (in Cr)

    8060.13

  • Net Profit (in Cr)

    90.75

  • P/B

    7.33

  • Sector P/E

    58.57

  • P/E

    39.39

  • EV/EBITDA

    17.48

  • Debt/Equity (Industry)

    0.18

  • Interest Cover (Industry)

    12.19

  • ROCE (Industry)

    17.69

  • RONW (Industry)

    14.86

  • ROE

    16.91

  • ROCE

    25.93

  • Debt/Equity

    0.06

  • EPS (TTM)

    10.53

  • Dividend Yield

    0

  • Book Value

    36.79

  • Interest Cover

    39.89

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters60.9260.9371.0671.0671.06
FII5.374.954.853.232.41
DII20.9920.5113.4714.5414.97
Public12.7113.6110.6311.1711.56
Government00000

Read More

Technical Analysis

RSI

64.18

MACD

18.61

50 DMA

546.91

200 DMA

459.96

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic791.22679.27629.13567.32517.18455.37343.42
Fibonacci679.27636.50610.08567.32524.55498.13455.37
Camarilla609.79599.52589.26567.32568.74558.48548.21

Pivots Level: Classic

R3

+223.90

791.22

R2

+111.95

679.27

R1

+61.82

629.13

567.32
567.32
Pivot Point
LTP: 603.25

S1

-50.13

517.18

S2

-111.95

455.37

S3

-223.90

343.42

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    589.03

  • 20-EMA

    574.06

  • 30-EMA

    562.56

  • 50-EMA

    542.19

  • 100-EMA

    505.48

  • 200-EMA

    464.80

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
07 May 2026board-meetingsAccounts, Final Dividend
28 Jan 2026board-meetingsQuarterly Results
17 Nov 2025bonus2:1 Bonus Issue of Equity Shares28 Nov 2025
28 Oct 2025bonusBonus issue 2:128 Nov 2025
14 Oct 2025dividend₹7.00 Dividend /Share24 Oct 2025
24 Sept 2025dividendInterim Dividend - Rs. - 724 Oct 2025
05 Jul 2025agm
25 Jun 2025dividendFinal Dividend - Rs. - 2125 Jul 2025
23 Apr 2025dividend₹21.00 Dividend /Share25 Jul 2025
02 Aug 2024agm

Read More

Peer Comparison

Thyrocare Technologies Ltd logo

Thyrocare Technologies Ltd

Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

Apollo Hospitals Enterprise Ltd logo

Apollo Hospitals Enterprise Ltd

Aster DM Healthcare Ltd logo

Aster DM Healthcare Ltd

Max Healthcare Institute Ltd logo

Max Healthcare Institute Ltd

Narayana Hrudayalaya Ltd logo

Narayana Hrudayalaya Ltd

Read More

Thyrocare Technologies Ltd About

Thyrocare Technologies operates in the healthcare industry and is involved in providing quality diagnostic services to patients, laboratories and hospitals in India.

Industry

Healthcare

Founded

2000

Headquarters

CEO

Rahul Guha

Employees

Contact

Website icon

Website

http://www.thyrocare.com

Email icon

Email

ramjee.d@thyrocare.com; enquiry@thyrocare.com

Phone icon

Phone

91-22-27622762

Location icon

Location

D-37/1 TTC Industrial Area, MIDC Turbhe, Navi Mumbai, Maharashtra, 400703

Read More

Thyrocare Technologies Ltd Company History

YearHistory
2013
  • EIF acquired certain Equity Shares from Agalia.
  • The Subsidiary commenced operations at the PET-CT centres at Navi Mumbai and conducted over 1,000 scans in the first year of operation.
2014
  • The Company had installed, India’s first and the world’s longest track automation system for seamless sample movements from Siemens Limited.
  • The Company commissioned the operations in medical cyclotron facility in Navi Mumbai.
  • The Subsidiary commenced operations at the PET-CT centres in New Delhi and Hyderabad and the PET-CT centres at New Delhi conducted over 1,000 scans in the first year of operations.
2015
  • The Company opened RPLs in Delhi, Coimbatore, Hyderabad and Kolkata to expand its coverage and volume of tests and samples processed daily.
  • The Company acquired the equipment for testing of water samples and commenced operating the equipment under the brand name 'WHATERS'.
  • The Subsidiary has completed over 10,000 scans at the PET-CT centres in New Delhi, over 10,000 scans at the PET-CT centres in Navi Mumbai from the date of inception and over 1,000 scans at the PET-CT centres in Hyderabad since inception.
2016
  • Thyrocare Technologies are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities.
2024
  • Thyrocare Technologies Completed acquisition of Think Health Diagnostic Private Limited.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
ICICI PRUDENTIAL MUTUAL FUNDbulkBuy1748600125224 Oct 2025
NEO APEX VENTURE LLPbulkSell3542981252.8124 Oct 2025
EASTSPRING INVESTMENTS INDIA CONSUMER EQUITY OPEN LIMITEDbulkBuy319750125224 Oct 2025
DOCON TECHNOLOGIES PRIVATE LIMITEDbulkSell53328601252.0324 Oct 2025
HDFC MUTUAL FUNDbulkBuy443650125224 Oct 2025
NEO APEX VENTURE LLPbulkBuy3542981252.124 Oct 2025
ADITYA BIRLA SUN LIFE MUTUAL FUNDbulkBuy1033015125224 Oct 2025
HSBC MUTUAL FUND MIDCAP FUNDbulkBuy666133125224 Oct 2025
GRAVITON RESEARCH CAPITAL LLPbulkSell7252351310.3315 Oct 2025
GRAVITON RESEARCH CAPITAL LLPbulkBuy7252351311.6615 Oct 2025

Read More

Thyrocare Technologies Ltd News

Thyrocare Technologies Q1FY26 Results

Thyrocare Technologies reported a 34% YoY rise in consolidated net profit to ₹51.33 crore for Q1FY26, driven by 24% revenue growth to ₹244.17 crore.

24 Jul 2026

companies

Thyrocare Technologies posts Q4FY27 results

Thyrocare Technologies Limited has made the audio recording of its earnings call available. The discussion covered unaudited financial results for the quarter ended June 30, 2026.

23 Jul 2026

companies

Thyrocare evaluates demerger of radiology business

Thyrocare Technologies Ltd's board approved evaluating the demerger of Nueclear Healthcare's radiology business. The proposal is at an in-principle stage.

23 Jul 2026

companies

Thyrocare Q1 net profit rises 39% to ₹51.33 crore

Thyrocare Technologies reported a consolidated net profit of ₹51.33 crore for Q1FY26, up from ₹38.29 crore in the year-ago period. Revenue from operations increased to ₹240.02 crore. The Board also re-appointed M/s. Ernst & Young LLP as Internal Auditor for FY27.

23 Jul 2026

companies

Thyrocare to hold Q1FY27 earnings call on July 23

Thyrocare Technologies Limited will host an earnings conference call on July 23, 2026, at 6:00 PM IST to discuss unaudited financial results for Q1FY27.

16 Jul 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number